Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation

BACKGROUND: There are no proven effective treatments that can reduce the mortality in heart failure with preserved ejection fraction (HFpEF), probably due to its heterogeneous nature which will weaken the effect of therapy in clinical studies. We evaluated the effect of beta-blocker treatment in HFp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yanhua, Guo, Suxia, Huang, Ziyao, Deng, Chunhua, Chen, Lihua, Zhou, Guoxiang, Jian, Zhengwei, He, Ruping, Huang, Zhichao, Yao, Yongzhao, Lu, Jiongbin, Hua, Zhiwen, Huang, Yuli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243006/
https://www.ncbi.nlm.nih.gov/pubmed/32454997
http://dx.doi.org/10.1155/2020/3059864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243006/
https://www.ncbi.nlm.nih.gov/pubmed/32454997
http://dx.doi.org/10.1155/2020/3059864

Ejemplares similares